Skip to main content
logo
Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.2200
+0.0080 (3.77%)
At close: May 6, 2026, 4:00 PM EDT
0.2110
-0.0090 (-4.09%)
Pre-market: May 7, 2026, 7:40 AM EDT

Calidi Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
29265487195
Market Cap Growth
-83.56%-66.78%-51.63%-38.56%-55.34%-
Enterprise Value
-0.614.0719.385797.97424.44
Last Close Price
0.221.1713.80181.201220.401177.20
PE Ratio
--0.20-0.39-0.87-3.40-17.84
PS Ratio
----1939.97435.40
PB Ratio
0.432.2916.91-6.51-1.73-13.31
P/TBV Ratio
0.251.346.00-3.10-1.71-13.19
P/FCF Ratio
--0.40-1.32-1.95-6.40-24.50
P/OCF Ratio
--0.40-1.32-1.99-6.61-25.15
EV/Sales Ratio
----2177.22945.29
EV/EBITDA Ratio
--0.22-0.96-2.06-4.28-41.10
EV/EBIT Ratio
--0.20-0.89-1.97-4.24-40.49
EV/FCF Ratio
--0.19-0.98-2.07-7.18-53.19
Debt / Equity Ratio
0.280.281.32-0.65-0.040
Debt / EBITDA Ratio
-0.14-0.14-0.35-0.26-0.21-
Debt / FCF Ratio
-0.12-0.12-0.36-0.26-0.35-
Net Debt / Equity Ratio
-0.81-0.81-1.67-0.64-0.090.07
Net Debt / EBITDA Ratio
0.160.160.13-0.19-0.190.10
Net Debt / FCF Ratio
0.140.140.13-0.19-0.330.13
Asset Turnover
-0000.000.00
Quick Ratio
1.421.421.010.190.012.59
Current Ratio
1.591.591.080.420.023.61
Return on Equity (ROE)
-700.65%-700.65%708.76%119.07%-29.15%-5.08%
Return on Assets (ROA)
-175.83%-175.83%-180.07%-459.86%-19.75%-4.53%
Return on Invested Capital (ROIC)
-594.17%-594.17%-1126.08%1030.11%-20.58%-4.56%
Return on Capital Employed (ROCE)
-421.32%-421.32%-973.66%142.80%-24.22%-4.53%
Earnings Yield
-1052.61%-508.55%-258.70%-114.58%-29.40%-5.61%
FCF Yield
-881.17%-248.43%-75.97%-51.40%-15.63%-4.08%
Buyback Yield / Dilution
-544.98%-544.98%-373.05%-99.06%56.96%-
Total Shareholder Return
-544.98%-544.98%-373.05%-99.06%56.96%-
Updated Mar 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q